Skip to content
Friday, January 27, 2023
Latest:
  • When visible meets invisible: the importance of psychological screening and intervention in pediatric dermatology
  • Savor brunch nutritiously
  • Journaling for mental health
  • Ataxia mutant protein uses distinct partners to drive toxicity in different brain cells
  • Recipe: Herb-rubbed Flank Steak

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

neuroblastoma

From The Labs 

Researchers identify an Achilles’ heel in neuroblastoma

August 16, 2022August 22, 2022cancer treatment, FATP2, fatty acid metabolism, metabolimics, MYCN, neuroblastoma, Research

A metabolic vulnerability in neuroblastoma could be exploited to overturn these tumors’ resistance to therapy.

Read more
From The Labs 

Turning the molecular clock back on halts neuroblastoma tumor growth

July 27, 2021July 27, 2021BMAL1, brain cancer, molecular clock, MYCN, neuroblastoma, Research, RORa

Restoring function of the molecular clock blocks tumor growth in advanced neuroblastoma and can make tumors more sensitive to conventional chemotherapy.

Read more
From The Labs 

CAR NKT cells, a promising step forward in the treatment of solid tumors

November 10, 2020November 10, 2020CAR NK T cells, clinical trial, Immunotherapy, neuroblastoma, Research, solid tumors

An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.

Read more
From The Labs 

Understanding the cancer risk in children with birth defects

June 25, 2020June 25, 2020ALL, Birth defects, cancer risk, hepatoblastoma, neuroblastoma, pediatric oncology, Research

Understanding the cancer risk in children with birth defects has been a challenge. Although scientific studies suggest that birth defects increase the risk of cancer,

Read more
From The Labs 

From the labs to bedside: First-in-human trial shows promise in treating neuroblastoma

May 28, 2019May 28, 2019chimeric antigen, Clinical Trials, GD2, GD2-CAR, Immunotherapy, neuroblastoma, Research

Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: Adult-born neurons made the cover

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951